人组织驻留CCR5+ T细胞区室在炎症中维持保护性和功能特性
研究采用单细胞分析方法,检测人血、健康及炎症黏膜组织中CCR5+ T细胞区室,发现65%的CD4组织驻留记忆T(TRM)细胞表达CCR5,且该区室在炎症组织及马拉维若治疗下均稳定维持,提示其可在缺乏CCR5介导的外周T细胞募集时维持屏障免疫。
要点
- 65%的CD4 TRM细胞表达CCR5,富集于上皮层及附近。
- CCR5+ TRM不仅限于TH1型,还包含大量产TH17及稳定调节性T细胞群体。
- 炎症组织及马拉维若治疗下CCR5+ TRM区室仍稳定维持。
核心结论
- 人CCR5+ TRM区室在功能和空间上具备维持屏障免疫的能力,即使缺乏CCR5介导的外周新募集T细胞。
研究设计与样本
- 采用单细胞分析方法检测人血、健康及炎症黏膜组织中的CCR5+ T细胞区室。
- 利用CHARM-03临床试验的组织样本分析马拉维若治疗下CCR5+ TRM的变化。
主要发现
- 65%的CD4 TRM细胞区室表达CCR5。
- CCR5+ TRM细胞富集于上皮层及附近,不仅限于TH1型细胞,还包含大量产TH17细胞和稳定的调节性T细胞群体。
- CCR5+ TRM区室在炎症组织中稳定维持,包括TH17和调节性T细胞群体的保留。
- 使用CHARM-03临床试验组织发现,马拉维若治疗期间人黏膜组织中CCR5+ TRM得以保留。
临床怎么用
- CCR5拮抗剂用于炎症驱动疾病时,可能不影响组织驻留CCR5+ TRM介导的屏障免疫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CCR5 is thought to play a central role in orchestrating migration of cells in response to inflammation. CCR5 antagonists can reduce inflammatory disease processes, which has led to an increased interest in using CCR5 antagonists in a wide range of inflammation-driven diseases. Paradoxically, these antagonists appear to function without negatively affecting host immunity at barrier sites. We reasoned that the resolution to this paradox may lie in the CCR5+ T cell populations that permanently reside in tissues. We used a single-cell analysis approach to examine the human CCR5+ T cell compartment in the blood, healthy, and inflamed mucosal tissues to resolve these seemingly contradictory observations. We found that 65% of the CD4 tissue-resident memory T (TRM) cell compartment expressed CCR5. These CCR5+ TRM cells were enriched in and near the epithelial layer and not only limited to TH1-type cells but also contained a large TH17-producing and a stable regulatory T cell population. The CCR5+ TRM compartment was stably maintained even in inflamed tissues including the preservation of TH17 and regulatory T cell populations. Further, using tissues from the CHARM-03 clinical trial, we found that CCR5+ TRM are preserved in human mucosal tissue during treatment with the CCR5 antagonist Maraviroc. Our data suggest that the human CCR5+ TRM compartment is functionally and spatially equipped to maintain barrier immunity even in the absence of CCR5-mediated, de novo T cell recruitment from the periphery.
引用
- Woodward Davis AS, Roozen HN, Dufort MJ, et al. The human tissue-resident CCR5+ T cell compartment maintains protective and functional properties during inflammation. Sci Transl Med. 2019. PMID: 31801887. doi:10.1126/scitranslmed.aaw8718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。